Paper
0
Use of Post-Induction Treatment in Mantle Cell Lymphoma (MCL) in Spain. Do All Young Fit Patients Need Autologous Stem Cell Transplantation (ASCT) in the Era of High-Dose Ara-C (HiDAC) and Rituximab Maintenance?
Authors
Ana Marín‐Niebla,Mariana Bastos‐Oreiro
Antonio Perez,Alba Touzón,Fátima Vicente,Marta Canelo,Ana Ubieto,Sonia Villambrosía,Ana Muntañola,Hugo Luzardo,Eduardo Ríos,Beatriz Cruz,Raúl Córdoba,Ana Carreres,Alejandro Martı́n,Ana García‐Noblejas,Carlos Grande,Pablo Martinez,Concepción Nicolás,Antonio Gutiérrez,Jose-Angel Rivas,Blanca Sánchez‐González,Rosalía Alonso,Eva Donato,Paola Gutiérrez,Daniel Belmonte,Silvia Cozzarelli,Sandra Ordoñez,Emilia Mano,Lucía Blanco,Eva Giné,Juan‐Manuel Sancho,Alberto García,Alicia Roldán,Pilar Gómez,Victor Garces,Pau Abrisqueta,Ana Jiménez‐Ubieto
+36 authors
,Alejandro MartínJournal
Published
Nov 5, 2024
Show more
Save
Tip0
TipSave
Abstract
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.